Dudediligence.

AN2 Therapeutics, Inc

ANTXNASDAQ · Pharmaceutical Preparations
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Aug 1110-QQuarterly report
  2. Aug 118-KResults of operations2.029.01
  3. Jun 88-KShareholder vote5.07
  4. Jun 48-KRegulation FD disclosure and other events7.018.019.01
  5. May 1110-QQuarterly report
  6. May 118-KResults of operations2.029.01
  7. Apr 20424B3Prospectus for an offering
  8. Apr 20424B5Prospectus for an offering
  9. Apr 9S-3Shelf registration
  10. Apr 98-KOther events8.019.01
  11. Mar 208-KOfficer or director change5.02
  12. Mar 1710-KAnnual report
  13. Mar 178-KResults of operations2.029.01
  14. Mar 108-KMaterial agreement and unregistered sale of shares1.013.027.019.01
  15. Jan 298-KOfficer or director change5.02
  16. Nov 12, 202510-QQuarterly report
  17. Nov 12, 20258-KResults of operations2.029.01
  18. Aug 12, 202510-QQuarterly report
  19. Aug 12, 20258-KFinancial statements and exhibits9.01
  20. Jun 20, 20258-KUnregistered sale of shares3.029.01
  21. Jun 11, 20258-KRegulation FD disclosure7.019.01
  22. May 27, 20258-KShareholder vote5.07
  23. May 13, 202510-QQuarterly report
  24. May 13, 20258-KFinancial statements and exhibits9.01
  25. May 1, 20258-KRegulation FD disclosure7.019.01
  26. Mar 25, 202510-KAnnual report
  27. Mar 25, 20258-KResults of operations2.029.01
  28. Nov 13, 202410-QQuarterly report
  29. Nov 13, 20248-KResults of operations2.029.01
  30. Nov 5, 20248-KOfficer or director change5.02